[The First Russian Consensus on the Multilevel Abobotulinumtoxin A Injections in Spastic Forms of Cerebral Palsy].

Spasticity treatment is one of the key aspects of the contemporary cerebral palsy (CP) rehabilitation that influences on the effectiveness of other methods. The paper presents the first Russian document that unites the recommendations for the BTA treatment of CP and could be used as the guideline for the multilevel injections. The Russian consensus on the multilevel botulinum toxin A (BTA) treatment of spastic CP is based on the international data and the results of national studies. The authors describe typical CP spasticity patterns in the upper and lower extremities, give recommended intervals for the BTA (Abobotulinum toxin A) dosages for the whole injection procedure and for the separate muscles. The method of dosage calculation for functional segments is also described. Attention is paid to the frequency, optimal intervals between the repeated injections and the whole duration of BTA treatment. The authors discuss effectiveness and safety of BTA, factors that potentially influence the results of the injections, including ultrasound and electromyography control, and indications for the continuation and termination of treatment.

[1]  В. П. Зыков,et al.  Многоуровневые инъекции ботулинического токсина типа а (абоботулотоксина) при лечении спастических форм детского церебрального паралича: ретроспективное исследование опыта 8 российских центров , 2016 .

[2]  E. Dabrowski,et al.  AbobotulinumtoxinA for Equinus Foot Deformity in Cerebral Palsy: A Randomized Controlled Trial , 2016, Pediatrics.

[3]  Reinald Brunner,et al.  Best Clinical Practice in Botulinum Toxin Treatment for Children with Cerebral Palsy , 2015, Toxins.

[4]  А. Р. Артеменко,et al.  Botulinum toxin , 2015, Reactions Weekly.

[5]  I. Novak,et al.  A systematic review of interventions for children with cerebral palsy: state of the evidence , 2013, Developmental medicine and child neurology.

[6]  Лейла Сеймуровна Намазова-баранова,et al.  Паттерны спастичности мышц верхних конечностей и применение ботулинотерапии у пациентов с детским церебральным параличом с поражением рук , 2013 .

[7]  Лейла Сеймуровна Намазова-баранова,et al.  КОНТРОЛЬ ТОЧНОСТИ ИНЪЕКЦИЙ БОТУЛИНИЧЕСКОГО ТОКСИНА ТИПА А ПРИ СПАСТИЧЕСКИХ ФОРМАХ ДЕТСКОГО ЦЕРЕБРАЛЬНОГО ПАРАЛИЧА: ВЫБОР МЕТОДИКИ , 2013 .

[8]  J. Funk,et al.  Off Label Use of Botulinum Toxin in Children under Two Years of Age: A Systematic Review , 2013, Toxins.

[9]  Владимир Маркович Кенис.  Эффективность использования препаратов бутолотоксина при коррекции динамичекой эквинусной и эквиноварусной деформации стопы у детей с гемипаретической формой церебрального паралича , 2012 .

[10]  W. Drescher,et al.  The key-muscle concept: a long-term low-dose injection strategy for botulinum toxin A treatment in cerebral palsy. , 2012, Acta orthopaedica Belgica.

[11]  R. C. Seet,et al.  Accurate targeting of botulinum toxin injections: how to and why. , 2011, Parkinsonism & related disorders.

[12]  R. Strijers,et al.  Short- and long-term effects of selective dorsal rhizotomy on gross motor function in ambulatory children with spastic diplegia. , 2011, Journal of neurosurgery. Pediatrics.

[13]  R. Brunner,et al.  Preoperative botulinum toxin test injections before muscle lengthening in cerebral palsy , 2010, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[14]  K. Desloovere,et al.  Botulinum toxin assessment, intervention and after‐care for lower limb spasticity in children with cerebral palsy: international consensus statement , 2010, European journal of neurology.

[15]  S Hayek,et al.  The Effect of Injections of Botulinum Toxin Type a Combined with Casting on the Equinus Gait of Children with Cerebral Palsy Patients and Methods , 2022 .

[16]  K. Alter.  High-frequency ultrasound guidance for neurotoxin injections. , 2010, Physical medicine and rehabilitation clinics of North America.

[17]  S. Berweck,et al.  Botulinum toxin assessment, intervention and follow‐up for paediatric upper limb hypertonicity: international consensus statement , 2010, European journal of neurology.

[18]  W. Chang,et al.  Short-Term Effects of Combined Serial Casting and Botulinum Toxin Injection for Spastic Equinus in Ambulatory Children with Cerebral Palsy , 2010, Yonsei medical journal.

[19]  K. Desloovere,et al.  The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb , 2010, Journal of children's orthopaedics.

[20]  Brooke Adair,et al.  Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy , 2010, Developmental medicine and child neurology.

[21]  L. Morrison,et al.  Practice Parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review) , 2010, Neurology.

[22]  S. Brochard,et al.  Effectiveness of nitrous oxide and analgesic cream (lidocaine and prilocaine) for prevention of pain during intramuscular botulinum toxin injections in children. , 2009, Annals of physical and rehabilitation medicine.

[23]  I. Pascual-Castroviejo,et al.  Safety of botulinum toxin type A in children younger than 2 years. , 2009, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[24]  J. Gracies,et al.  Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologySYMBOL , 2008, Neurology.

[25]  A. Blackmore,et al.  A systematic review of the effects of casting on equinus in children with cerebral palsy: an evidence report of the AACPDM , 2007, Developmental medicine and child neurology.

[26]  F. Heinen,et al.  Botulinum toxin treatment of children with cerebral palsy — a short review of different injection techniques , 2006, Neurotoxicity Research.

[27]  H. Graham,et al.  Accuracy of Intramuscular Injection of Botulinum Toxin A in Juvenile Cerebral Palsy: A Comparison Between Manual Needle Placement and Placement Guided by Electrical Stimulation , 2005, Journal of pediatric orthopedics.

[28]  Florian Heinen,et al.  Sonography-guided injection of botulinum toxin in children with cerebral palsy , 2004, The Lancet.

[29]  M. Childers.  The importance of electromyographic guidance and electrical stimulation for injection of botulinum toxin. , 2003, Physical medicine and rehabilitation clinics of North America.

[30]  A. Bakheit.  Botulinum toxin in the management of childhood muscle spasticity: comparison of clinical practice of 17 treatment centres , 2003, European journal of neurology.

[31]  S. Ashwal,et al.  CME Practice parameter : Evaluation of children and adolescents with recurrent headaches Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society , 2002 .

[32]  Beth P. Smith,et al.  Technique for Iliopsoas Ultrasound-Guided Active Electromyography-Directed Botulinum A Toxin Injection in Cerebral Palsy , 2002, Journal of pediatric orthopedics.

[33]  C. Cans.  Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers , 2000, Developmental medicine and child neurology.

[34]  R. Palisano,et al.  Development and reliability of a system to classify gross motor function in children with cerebral palsy , 1997, Developmental medicine and child neurology.

[35]  Д. Г. Курбатов,et al.  Андрология. Фармакология без ошибок под редакцией акад.РАН Камалова А.А. руководство для врачей , 2017 .

[36]  A. Tilton.  189. Evidence-based review of safety and efficacy of botulinum neurotoxin in cerebral palsy , 2015 .

[37]  S. Leonchuk,et al.  [The results of single-event multilevel orthopedic surgeries and the early rehabilitation used in complex with botulinum toxin treatment in patients with spastic forms of cerebral palsy]. , 2015, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[38]  L. Namazova-Baranova,et al.  [Selection of a dose of the botulinum toxin A in spastic forms of cerebral palsy]. , 2015, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[39]  Kenis Vm.  Efficacy of botulinum toxin in the treatment of dynamic equinus and equinovarus foot deformities in children with hemiplegic cerebral palsy , 2012 .

[40]  K. Desloovere,et al.  The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. , 2010, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[41]  M. Delgado,et al.  Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology and the practice committee of the child neurology society. , 2010, Neurology.

[42]  H. Graham,et al.  Chapter 14 – Treatment of Motor Disorders in Cerebral Palsy with Botulinum Neurotoxin , 2009 .

[43]  L. Fetters,et al.  Efficacy of Ankle-Foot Orthoses on Gait of Children with Cerebral Palsy: Systematic Review of Literature , 2008, Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association.

[44]  Kaat Desloovere,et al.  The effects of quantitative gait assessment and botulinum toxin a on musculoskeletal surgery in children with cerebral palsy. , 2006, The Journal of bone and joint surgery. American volume.